Other Choroidal Disorders


Choroidal Rupture

Jorge Ruiz-Medrano
Jay Chhablani
Clínico San Carlos University Hospital, Ophthalmology Unit, Madrid, Spain
LV Prasad Eye Institute, Hyderabad, India

Abstract

Choroidal ruptures involve a tear of the retinal pigment epithelium, Bruch’s membrane, and choroidal tissue as a consequence of trauma to the eye. Choroidal rupture caused by blunt trauma to the eye may occur at the site of the impact in the case of direct ruptures, or as a consequence of a countercoup, just opposite to it, in indirect tears. Most of them take place temporal to the optic disc and usually affect the macular area and the fovea. Diseases affecting the consistency of Bruch’s membrane are more susceptible to choroidal ruptures after trauma, like angioid streaks.

Visual prognosis is marked by location, presence of intraocular hemorrhage, retinal involvement (retinal tears and detachment, retinal edema), and development of choroidal neovascularization. Current therapeutic approaches are focused on the management of complications.

Keywords: Choroidal rupture; Trauma; Choroidal neovascularization; Bruch’s membrane; Angioid streaks

Introduction

The first report of a choroidal rupture goes back to 1854, when von Graefe described it for the first time. It involves a tear of the retinal pigment epithelium (RPE), Bruch’s membrane, and choroidal tissue as a consequence of trauma to the eye. Choroidal rupture caused by blunt trauma to the eye may occur at the site of the impact in the case of direct ruptures, or as a consequence of a countercoup, just opposite to it, in indirect tears.

According to published series, up to 80% of choroidal ruptures are classified as indirect, and the vast majority of these are caused by blunt trauma. Most of them take place temporal to the optic disc and usually affect the macular area and the fovea, showing a crescent shape. On the other hand, open-globe injuries appear to be the cause of choroidal ruptures in up to 28% of the cases. In these cases lesions are more typically located anteriorly, parallel to the ora serrata .

There are several theories about the mechanism that may cause an indirect choroidal break. The most accepted suggests that antero-posterior compressions and deformations cause an equatorial expansion of the globe. This force is conducted to the optic nerve and radiated from the peripapillary uveo-scleral tether. Bruch’s membrane tissue has properties that make it the most susceptible target to be damaged in indirect traumas. While retinal tissue is more elastic than Bruch’s membrane, the sclera shows more resistance to tension thanks to its stiffness. This is why they are both usually spared.

Diseases affecting the consistency of Bruch’s membrane are more susceptible to choroidal ruptures after trauma, like angioid streaks, as will be discussed later. Older theories relating the tears to vascular necrosis as a consequence of the trauma are not as supported as the previous one.

Ocular Manifestations and Clinical Course

The most common clinical presentation is a subretinal hemorrhage that may hide the actual tear in the early phases ( Fig. 19.1.1 ) and, in rare cases, there may be multiple breaks. After blood is resorbed, the choroidal rupture becomes visible taking a crescent shape, concentric to the optic nerve head ( Fig. 19.1.2 ). Although it has not been found to be a predictive factor by some authors, initial visual acuity (VA) ranges from 20/20 to light perception, depending on the affected area.

Figure 19.1.1, Fundus photograph showing choroidal rupture with subretinal hemorrhage.

Figure 19.1.2, Fundus photograph shows peripapillary choroidal rupture (A) and corresponding SD-OCT (B).

Visual prognosis is marked by location, presence of intraocular hemorrhage, retinal involvement (retinal tears and detachment, retinal edema), and development of choroidal neovascularization (CNV).

Secretan et al. published a review of 79 cases reaching several conclusions: They stated that ruptures located less than 200 µm from the foveal avascular zone (FAZ) and between 200 and 1500 µm from the FAZ were significantly more likely to develop CNV than those located farther than 1500 µm from the FAZ. They also found breaks larger than 4000 µm to predispose for the development of CNV, wherever they were located; 82% of their patients developed CNV during the first year of follow-up.

Treatment

Although traumatic CNV usually regress spontaneously, several treatments have been proposed through the years, from photodynamic therapy (PDT), going through surgical extraction and laser photocoagulation until the age of anti-vascular endothelial growth factor (VEGF) drugs ( Fig. 19.1.3 ).

Figure 19.1.3, Fundus photograph (A) shows choroidal rupture with suspicious CNV secondary to choroidal rupture. Fundus fluorescein angiography shows early hyperfluorescence (B) with late leakage (D). SD-OCT (E) suggests presence of CNV with subretinal fluid. After anti-VEGF therapy OCT shows scarred CNV with resolution of subretinal fluid.

Both bevacizumab and ranibizumab have shown good results for the treatment of CNV related to choroidal ruptures. Mean number of injections goes from 2.5 injections in 52 months up to monthly injections depending on the treatment regimen established. Rosina et al. state that patients free from CNV reactivation for about a year show a smaller recurrence rate. Furthermore, each recurrence increases the risk for further reactivation; therefore, frequent controls during follow-up are mandatory. Some authors report promising results, stabilizing or improving VA in 62.9% of the eyes treated with ranibizumab.

References

  • 1. Von Graefe A.: Zwei falle von rupture der choroidea [Two cases of choroidal rupture]. Graefes Arch Clin Exp Ophthalmol 1854; 1: pp. 402.
  • 2. Ament C.S., Zacks D.N., Lane A.M., et. al.: Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol 2006; 124: pp. 957-966.
  • 3. Williams D.F., Mieler W.F., Williams G.A.: Posterior segment manifestations of ocular trauma. Retina 1990; 10: pp. S35-S44.
  • 4. Hart J.C., Natsikos V.E., Raistrick E.R., Doran R.M.: Indirect choroidal tears at the posterior pole: a fluorescein angiographic and perimetric study. Br J Ophthalmol 1980; 64: pp. 59-67.
  • 5. Secretan M., Sickenberg M., Zografos L., Piguet B.: Morphometric characteristics of traumatic choroidal ruptures associated with neovascularization. Retina 1998; 18: pp. 62-66.
  • 6. Wyszynski R.E., Grossniklaus H.E., Frank K.E.: Indirect choroidal rupture secondary to blunt ocular trauma. A review of eight eyes. Retina 1988; 8: pp. 237-243.
  • 7. Aguilar J.P., Green W.R.: Choroidal rupture: a histopathologic study of 47 cases. Retina 1984; 4: pp. 269-275.
  • 8. Patel M.M., Chee Y.E., Eliott D.: Choroidal rupture: a review. Int Ophthalmol Clin 2013; 53: pp. 69-78.
  • 9. Osterberg G.: Three cases of acute traumatic chorioretinitis (Siegrist): one of them histologically examined. Acta Ophthalmol Copenh 1936; 14: pp. 460-470.
  • 10. Wagenmann A.: Zur Pathologiscen anatomie der aderhautruptur und iridodialyse. Bericht Detsche Ophth Ges 1902; 30: pp. 278-282.
  • 11. Goldman D., Vora R., Reichel E.: Traumatic choroidal rupture with submacular hemorrhage treated with pneumatic displacement. Retina 2014; 34: pp. 1258-1260.
  • 12. Mennel S., Hausmann N., Meyer C.H., Peter S.: Photodynamic therapy and indocyanine green guided feeder vessel photocoagulation of choroidal neovascularization secondary to choroid rupture after blunt trauma. Graefes Arch Clin Exp Ophthalmol 2005; 243: pp. 68-71.
  • 13. Harissi-Dagher M., Sebag M., Gauthier D., Marcil G., Labelle P., Arbour J.D.: Photodynamic therapy in young patients with choroidal neovascularization following traumatic choroidal rupture. Am J Ophthalmol 2005; 139: pp. 726-728.
  • 14. Conrath J., Forzano O., Ridings B.: Photodynamic therapy for subfoveal CNV complicating traumatic choroidal rupture. Eye (Lond) 2004; 18: pp. 946-947.
  • 15. Abri A., Binder S., Pavelka M., Tittl M., Neumüller J.: Choroidal neovascularization in a child with traumatic choroidal rupture: clinical and ultrastructural findings. Clin Experiment Ophthalmol 2006; 34: pp. 460-463.
  • 16. Fleckner M.R., Hochman M.A., Buzney S.M., Weiter J.J., Tolentino F.I., Khadem J.J.: Complications of surgery for subfoveal choroidal neovascularization. Int Ophthalmol Clin 2000; 40: pp. 201-214.
  • 17. Gass J.D.: Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994; 118: pp. 285-298.
  • 18. Gross J.G., King L.P., de Juan E., Powers T.: Subfoveal neovascular membrane removal in patients with traumatic choroidal rupture. Ophthalmology 1996; 103: pp. 579-585.
  • 19. Fuller B., Gitter K.: Traumatic choroidal rupture with late serous detachment of macula. Report of successful argon laser treatment. Arch Ophthalmol 1973; 89: pp. 354-355.
  • 20. Hilton G.: Late serosanguineous detachment of the macula after traumatic choroidal rupture. Am J Ophthalmol 1975; 79: pp. 997-1000.
  • 21. Neri P., Salvolini S., Mariotti C., Mercanti L., Celani S., Giovannini A.: Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab (Avastin). Br J Ophthalmol 2009; 93: pp. 155-158.
  • 22. Rosina C., Romano M., Cigada M., de Polo L., Staurenghi G., Bottoni F.: Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study. Eur J Ophthalmol 2015; 25: pp. 47-50.
  • 23. Tilleul J., Mimoun G., Querques G., et. al.: Intravitreal ranibizumab for choroidal neovascularization in angioid streaks: four-year follow-up. Retina 2016; 36: pp. 483-491.
  • 24. Mimoun G., Tilleul J., Leys A., Coscas G., Soubrane G., Souied E.: Intravitreal ranibizumab for choroidal neovascularization in angioid streaks. Am J Ophthalmol 2010; 150: pp. 692-700.
  • 25. Gliem M., Figuer R.P., Fimmers R., Brinkmann C.K., Holz F.G., Charbel P.: Treatment of choroidal streaks. A comprehensive review. Retina 2013; 33: pp. 1300-1314.

Angioid Streaks

Jorge Ruiz-Medrano
Jay Chhablani
Clínico San Carlos University Hospital, Ophthalmology Unit, Madrid, Spain
LV Prasad Eye Institute, Hyderabad, India

Abstract

Angioid streaks are degenerations and irregular breaks in Bruch’s membrane together with a consequent atrophy of the RPE above them, ophthalmoscopically visible as irregular lines that spread radially form the optic nerve. Calcium deposits make Bruch’s membrane more brittle and less resistant to trauma. Although they are not necessarily present in every affected patient, systemic associations of angioid streaks include pseudoxanthoma elasticum, Ehlers–Danlos and Marfan syndromes, Paget’s disease, acromegaly and several blood dyscrasias like thalassemia, spherocytosis, and sickle-cell anemia. Patients showing this disease are usually asymptomatic until complications arise. The most frequent of them is the development of traumatic CNV. Current therapeutic approaches are focused on the management of complications.

Keywords: Angioid streaks; Choroidal neovascularization; Choroidal rupture; Marfan; Pseudoxantoma elasticum

Introduction

Angioid streaks is the term used to describe visible irregular lines that spread radially form the optic nerve, with a variable width which funduscopically seem red-brown. It is their similarity to retinal vessels that is responsible for their name, and were first described in 1889 by Doyne during the exploration of traumatized eyes.

Angioid streaks are the ophthalmoscopic manifestations of calcific degeneration and irregular breaks in Bruch’s membrane together with a consequent atrophy of the RPE above them. Calcium deposits make Bruch’s membrane more brittle and less resistant to trauma (external, muscle traction, pressure on the eye), being responsible for the choroidal ruptures involved in these patients. Latest theories demonstrate an absence of a systemic antimineralization factor that leads to the calcification Bruch’s membrane and other connective tissues that are rich in elastic fibers. Although they are not necessarily present in every affected patient, systemic associations of angioid streaks include pseudoxanthoma elasticum, Ehlers–Danlos and Marfan syndromes, Paget’s disease, acromegaly and several blood dyscrasias like thalassemia, spherocytosis, and sickle-cell anemia. Other less common conditions associated to this pathology are listed in Table 19.2.1 .

Table 19.2.1
Systemic Associations of Angioid Streaks
Pseudoxanthoma elasticum
Marfan syndrome
Ehlers–Danlos syndrome
Paget’s disease
Acromegaly
Sturge–Weber syndrome
Spherocytosis
Sickle-cell anemia
Thalassemia
Hemolytic anemia
Neurofibromatosis
Tuberous sclerosis
Epilepsy
Trauma hypertension
Diabetes
Diffuse lipomatosis
Hypercalcinosis
Hyperphosphatemia
Hemochromatosis
Alpha–beta-lipoproteinemia

Patients showing this disease are usually asymptomatic until complications arise. The most frequent of them is the development of traumatic CNV, and prognosis depends on the macular involvement.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here